Literature DB >> 18495782

T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't.

Angela Dolganiuc1, Gyongyi Szabo.   

Abstract

The mechanism behind the apparent lack of effective antiviral immune response in patients with chronic hepatitis C virus (HCV) infection is poorly understood. Although multiple levels of abnormalities have been identified in innate and adaptive immunity, it remains unclear if any of the subpopulations of T cells with regulatory capacity (Tregs) contribute to the induction and maintenance of HCV persistence. In this review, we summarize the current knowledge about Tregs as they relate to HCV infection.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18495782      PMCID： PMC2516897          DOI： 10.1189/jlb.1107770

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


  92 in total

1.  Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels.

Authors:  F Bolacchi; A Sinistro; C Ciaprini; F Demin; M Capozzi; F C Carducci; C M J Drapeau; G Rocchi; A Bergamini
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells.

Authors:  Zoltán Fehérvári; Shimon Sakaguchi
Journal:  Int Immunol       Date:  2004-11-01       Impact factor: 4.823

3.  Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.

Authors:  Henry Radziewicz; Chris C Ibegbu; Marina L Fernandez; Kimberly A Workowski; Kamil Obideen; Mohammad Wehbi; Holly L Hanson; James P Steinberg; David Masopust; E John Wherry; John D Altman; Barry T Rouse; Gordon J Freeman; Rafi Ahmed; Arash Grakoui
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

4.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

5.  T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Authors:  Tobias Boettler; Hans Christian Spangenberg; Christoph Neumann-Haefelin; Elisabeth Panther; Simonetta Urbani; Carlo Ferrari; Hubert E Blum; Fritz von Weizsäcker; Robert Thimme
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Association between hepatitis C infection and other infectious diseases: a case for targeted screening?

Authors:  Hashem B El-Serag; Bhupinderjit Anand; Peter Richardson; Linda Rabeneck
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

7.  Regulatory T cells in hepatitis C virus infection.

Authors:  Kyong-Mi Chang
Journal:  Hepatol Res       Date:  2007-10       Impact factor: 4.288

8.  Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.

Authors:  Randy S Longman; Andrew H Talal; Ira M Jacobson; Matthew L Albert; Charles M Rice
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

9.  Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

Authors:  Tobias Bopp; Christian Becker; Matthias Klein; Stefan Klein-Hessling; Alois Palmetshofer; Edgar Serfling; Valeska Heib; Marc Becker; Jan Kubach; Steffen Schmitt; Sabine Stoll; Hansjörg Schild; Martin S Staege; Michael Stassen; Helmut Jonuleit; Edgar Schmitt
Journal:  J Exp Med       Date:  2007-05-14       Impact factor: 14.307

10.  Dual T cell receptor alpha chain T cells in autoimmunity.

Authors:  J I Elliott; D M Altmann
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307
View more
  11 in total

Review 1.  Tolerance--is it worth it?

Authors:  Erik B Finger; Terry B Strom; Arthur J Matas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-02-01       Impact factor: 6.915

2.  Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology.

Authors:  Helal F Hetta; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Mahmoud I Nassar; Ahmed Medhat; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  J Gastroenterol Hepatol       Date:  2015-10       Impact factor: 4.029

Review 3.  NK cells, innate immunity and hepatitis C infection after liver transplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

Review 4.  Th17 cells and their associated cytokines in liver diseases.

Authors:  Fouad Lafdil; Andrew M Miller; Sung Hwan Ki; Bin Gao
Journal:  Cell Mol Immunol       Date:  2010-03-22       Impact factor: 11.530

Review 5.  Viral vaccines and CTL response.

Authors:  Stacie N Woolard; Uday Kumaraguru
Journal:  J Biomed Biotechnol       Date:  2010-03-31

6.  Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid.

Authors:  Richard M Dunham; Manoj Thapa; Victoria M Velazquez; Elizabeth J Elrod; Timothy L Denning; Bali Pulendran; Arash Grakoui
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

Review 7.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

8.  PD-1 tempers Tregs in chronic HCV infection.

Authors:  Henry Radziewicz; Richard M Dunham; Arash Grakoui
Journal:  J Clin Invest       Date:  2009-03       Impact factor: 14.808

9.  Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.

Authors:  Angela Dolganiuc; Karen Kodys; Christopher Marshall; Banishree Saha; Shuye Zhang; Shashi Bala; Gyongyi Szabo
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C.

Authors:  Bettina Langhans; Hans Dieter Nischalke; Simone Arndt; Ingrid Braunschweiger; Jacob Nattermann; Tilman Sauerbruch; Ulrich Spengler
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.